Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2010-06-05 Governance Information
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
控股子公司内部控制制度（2010年4月）
Governance Information Classification · 95% confidence The document is a detailed internal control system for the company's controlling subsidiaries, covering governance structure, personnel management, financial management, investment decision management, audit supervision, performance evaluation, and archival management. It is a comprehensive policy and procedural document rather than a financial report, earnings release, or announcement. It does not contain financial statements, earnings data, or voting results. It is not a presentation or transcript. It is a governance-related document detailing internal control and management systems. Therefore, it fits best under Governance Information (CGR). The document length (6288 characters) and content confirm it is a full policy document, not a brief announcement or certification.
2010-06-05 Chinese
财务预算管理办法（2010年6月）
Governance Information Classification · 95% confidence The document is titled '财务预算管理办法' which translates to 'Financial Budget Management Measures' and details internal company policies and procedures for financial budgeting, including organization, preparation, execution, control, adjustment, and evaluation of budgets. It is a management or internal policy document rather than a financial report, earnings release, or regulatory filing. It does not contain financial statements, audit results, or shareholder meeting information. It is not an announcement or a report publication notice but a detailed internal governance document related to financial management practices. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 4795 characters, which is sufficient for a detailed policy document, not a brief announcement.
2010-06-05 Chinese
证券投资管理制度（2010年6月）
Governance Information Classification · 95% confidence The document is titled '证券投资管理制度' which translates to 'Securities Investment Management System'. It is a detailed internal policy document outlining the principles, management, account management, fund management, risk control, information isolation, internal reporting procedures, and responsibility accountability related to the company's securities investment activities. It references company laws, securities laws, and company articles of association, and includes procedural and governance details. It is not a financial report, earnings release, or announcement but rather a governance or management policy document. It does not contain financial statements or results, nor is it an announcement of a report. The content fits best under Governance Information (CGR) as it details internal rules and governance practices related to securities investment management within the company.
2010-06-05 Chinese
金融衍生品交易内部控制制度（2010年6月）
Governance Information Classification · 95% confidence The document is titled as an internal control system for financial derivatives trading of the company. It outlines policies, responsibilities, risk management, and internal control procedures related to financial derivatives trading. There is no indication that this is a financial report, earnings release, or regulatory filing. It is a governance-related document detailing internal rules and control mechanisms for a specific area of company operations. It does not contain financial statements or audit results, nor is it an announcement or presentation. Therefore, it fits best under Governance Information (CGR). The document length is 2351 characters, which is relatively short but the content is substantive and detailed about governance policies, not a mere announcement or certification.
2010-06-05 Chinese
关联交易管理制度（2010年3月）
Governance Information Classification · 95% confidence The document is titled '关联交易管理制度' which translates to 'Related Party Transaction Management System'. It outlines the company's policies, principles, and procedures for managing related party transactions, including definitions, scope, approval processes, disclosure requirements, and governance related to such transactions. It references relevant laws and stock exchange rules but does not contain financial statements, audit results, or earnings data. It is a governance and compliance document detailing internal rules and procedures rather than a financial report or announcement. Therefore, it fits best under Governance Information (CGR). The document length (6268 characters) and content confirm it is a full policy document, not a brief announcement or certification.
2010-06-05 Chinese
六届二十三次董事会会议决议公告暨关于召开2009年年度股东大会会议的通知
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 23rd meeting of the 6th Board of Directors of Zhongyuan Xiehe Stem Cell Bioengineering Co., Ltd., including numerous amendments to internal control systems, management rules, and governance policies. It also includes a notice for the 2009 Annual General Meeting (AGM) with details on meeting time, location, agenda items (such as approval of the 2009 annual report, board and supervisory reports, financial statements, profit distribution plan, and amendments to company bylaws), and shareholder registration procedures. The document contains voting results for the board meeting and references to the company's governance and internal control systems. The content is focused on board decisions and governance matters rather than financial results or audit reports. It is not a full annual report (10-K), nor an earnings release or audit report. It is not a proxy solicitation or voting results declaration, but rather a board meeting resolution announcement and AGM meeting notice. Therefore, the best fitting category is Board/Management Information (MANG). The document length is substantial and contains detailed content, not just an announcement of a report publication, so it is not RPA or RNS.
2010-06-05 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.